Detailed Narrative
Medicaid Profitability and Trend Management
Centene demonstrated significant progress in restoring Medicaid profitability in the back half of 2025, with the Q4 HBR improving to 93.0%, a 40 basis point sequential improvement and 190 basis points from Q2 levels. Key drivers of excess trend, including behavioral health, home health, and high-cost drugs, remained consistent. The company is actively managing costs through network optimization, clinical programs, rate advocacy, and aggressive fraud detection, exemplified by the ABA task force which identified and addressed outlier providers and inappropriate care patterns.
Marketplace Repositioning and Risk Adjustment
The Marketplace business saw fundamental medical cost trends slightly better than expected in Q4, and a favorable change in the view of 2025 risk adjustment. Despite the expiration of enhanced advanced premium tax credits, Ambetter membership is on track for approximately 3.5 million members by the end of Q1 2026, with over 30% enrolled in Bronze plans. Centene anticipates a meaningful payable position for 2026 risk adjustment and is working with Wakely to publish a report for industry visibility on market dynamics.
Medicare Strategy and IRA Impact
Centene's Medicare segment delivered strong results in 2025, with Q4 performance in line with expectations. The company is progressing towards its goal of breakeven Medicare Advantage results in 2027, intentionally reducing MA membership while increasing yields. The PDP business performed strongly in 2025 despite Inflation Reduction Act headwinds, and 2026 enrollment is tracking to high single-digit percentage growth. The 2027 advanced notice suggests pressured rates, but Centene remains focused on profitability and quality.
No Surprises Act (NSA) Challenges and Litigation
The No Surprises Act has become a source of increased costs and disputes, leading to a roughly 100 basis point increase in the Marketplace HBR in Q4 due to accruals for 2025 service dates. Centene views the NSA as being 'weaponized' by market participants and is advocating for reform. The company is adopting a more proactive and litigious posture, including filing a multimillion-dollar lawsuit against a New York provider for alleged fraudulent manipulation of claims.
Technology and AI Integration for Efficiency
Centene is systematically integrating AI into its operations to drive efficiency and enhance member experience. This includes proof points in accelerated prior authorization approvals, improved call center operations, enhanced member navigation, and advanced analytics for medical economics and payment integrity. The company plans to accelerate the integration of Generative AI and agentic capabilities into core operations in 2026 to drive automation and reimagine stakeholder experiences.
Capital Allocation and Debt Management
Centene ended 2025 with approximately $400 million of cash available for general corporate use. The company reduced debt by $189 million in Q4, bringing the debt-to-cap ratio to 46.5%. While no share buyback is reflected in the 2026 guidance, Centene will continue to assess capital deployment opportunities as it generates excess cash and aims for continued deleveraging to reduce interest expense.